Table 1 presents a summary of findings on copeptin as a prognostic biomarker in acute ischemic stroke, highlighting the number and types of patients included, assessed biomarkers, evaluated outcomes (stroke severity, stroke occurrence, short-term and long-term prognosis, scales used, stroke recurrence, and mortality), findings (correlations and predictions), and practical applications. Here, AVP is linked to Stroke.